Purpose Genetic and genomic health information increasingly informs routine clinical care
and treatment. This systematic review aimed to identify the barriers and facilitators to …

This paper describes the shared decision-making model, reviews its current status in the
mental health field, and discusses its potential impact on personalized medicine. Shared …

Developing a competent workforce will be crucial to realizing the promise of genomic
medicine. The preparedness of medical specialists without specific genetic qualifications to …

This study explores neurologists' and psychiatrists' knowledge, attitudes, and practices
concerning genetic tests. Psychiatrists (n= 5,316) and neurologists (n= 2,167) on the …

Pharmacogenetics seeks to improve patient drug response and decrease side effects by
personalizing prescriptions using genetic information. Since 2012, by one estimate, the …

Clinicians already face “personalized” medicine every day while experiencing the great
variation in toxicities and drug efficacy among individual patients. Pharmacogenetics studies …

Evidence is emerging of a growing societal consensus about appropriate and inappropriate
uses of genetic information. The Genetic Information Nondiscrimination Act of 2008 provides …

Background: Recent advances in schizophrenia genetics are shedding new light on
etiopathogenesis, but issues germane to translation of findings into clinical practice are …

The advent of genetic testing for psychiatric conditions raises difficult questions about when
and how the tests should be used. Development of policies regarding these issues may be …

Pharmacogenomics has an important role in the evolution of personalized medicine, and its
widespread uptake may ultimately depend on the interests and perspectives of key players …